+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

From
Bleeding Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 488 Pages
  • Global
From
Anal Fissure Treatment - Global Strategic Business Report - Product Thumbnail Image

Anal Fissure Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 381 Pages
  • Global
From
From
From
From
From
From
Alopecia - Pipeline Review, H2 2020 - Product Thumbnail Image

Alopecia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 222 Pages
  • Global
From
Genomic Collaboration and Licensing Deals 2018-2025 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2025

  • Report
  • May 2025
  • 350 Pages
  • Global
From
From
Cardiomyopathy Therapies - Global Strategic Business Report - Product Thumbnail Image

Cardiomyopathy Therapies - Global Strategic Business Report

  • Report
  • July 2025
  • 250 Pages
  • Global
From
From
From
From
Loading Indicator